These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8320361)

  • 1. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence.
    Burrows NP; Bhogal BS; Russell Jones R; Black MM
    J Cutan Pathol; 1993 Apr; 20(2):159-62. PubMed ID: 8320361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antinuclear antibodies of the skin: A rare phenomenon on direct immunofluorescence.
    Chhabra S; Arora SK; Minz RW; Dogra S
    Dermatol Online J; 2013 Apr; 19(4):15. PubMed ID: 24021374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
    Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
    Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro complement activation by antinuclear antibodies in the epidermis from patients with systemic sclerosis.
    Reimer G; Liebel G; Hornstein OP
    Br J Dermatol; 1984 Aug; 111(2):169-74. PubMed ID: 6380559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the in vivo reaction of antinuclear antibodies with epidermal cells.
    Izuno GT
    Br J Dermatol; 1978 Apr; 98(4):391-8. PubMed ID: 346041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo epidermal nuclear reactions: a selective process.
    Koelle MS; Kumar V; Beutner EH; Chorzelski TP
    Br J Dermatol; 1991 Jul; 125(1):48-52. PubMed ID: 1873202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Significance among Patients with
    Sirikudta W; Tuchinda P; Chularojanamontri L; Kulthanan K; Pinkaew S
    Indian J Dermatol; 2017; 62(2):226. PubMed ID: 28400653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.
    Velthuis PJ; Kater L; van der Tweel I; Meyling FG; Derksen RH; Hené RJ; van Geutselaar JA; Baart de la Faille H
    Ann Rheum Dis; 1990 Mar; 49(3):163-7. PubMed ID: 2181945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal nuclear immunoglobulin deposits in some connective tissue diseases: correlation with ENA antibodies.
    Andersen I; Andersen P; Elling P; Graudal H
    Ann Rheum Dis; 1983 Apr; 42(2):163-7. PubMed ID: 6342551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction.
    Chen ZY; Dobson RL; Ainsworth SK; Silver RM; Maricq HR
    Br J Dermatol; 1985 Jan; 112(1):15-22. PubMed ID: 3882123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin immunofluorescence studies on lupus erythematosus and other antinuclear-antibody-positive diseases.
    Grossman J; Callerame ML; Condemi JJ
    Ann Intern Med; 1974 Apr; 80(4):496-500. PubMed ID: 4621260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidermal nuclear fluorescence of normal skin in connective tissue diseases].
    Wollina U; Koch HJ; Knopf B
    Dermatol Monatsschr; 1984; 170(11):699-702. PubMed ID: 6394393
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P; Peltier AP; Allegre P; Civatte J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
    Magro CM; Dyrsen ME
    J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo cutaneous antinuclear antibody positivity in palisaded neutrophilic and granulomatous dermatitis.
    Dong J; Zubkov M; Weston G; Storonsky M; Murphy M
    J Cutan Pathol; 2020 Oct; 47(10):929-933. PubMed ID: 32335926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.